Psyence Biomedical (PBM) EPS (Weighted Average and Diluted) (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly EPS (Weighted Average and Diluted) of -$0.0 in Q3 2025, down 103.05% quarter-over-quarter from $0.03 in Q3 2024, and down 103.05% on a YoY basis from $0.03 in Q3 2024.
Psyence Biomedical (PBM) EPS (Weighted Average and Diluted) (2023 - 2025) Analysis & Trends
Psyence Biomedical's EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at -$0.0 for Q3 2025.
- In Q3 2025, EPS (Weighted Average and Diluted) fell 103.05% year-over-year to -$0.0; the TTM figure through Sep 2025 stood at -$0.0 (down 103.05% YoY), while the FY2025 annual figure was $5.24, up 100.11% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.0 for Q3 2025 at Psyence Biomedical, down from $0.03 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.03 in Q3 2024 to a low of -$0.07 in Q1 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 3 years, with a median of -$0.0 in 2025.
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 103.05% in 2025; the steepest drop was 103.05% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2023, then jumped by 150.87% to $0.03 in 2024, then tumbled by 103.05% to -$0.0 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q3 2025), $0.03 (Q3 2024), and -$0.07 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 6.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Sep 30, 2024 | 0.03 |
| Mar 31, 2023 | -0.07 |